Literature DB >> 20839784

Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine.

MaLing Gou1, Ke Men, Juan Zhang, YuHua Li, Jia Song, Shan Luo, HuaShan Shi, YanJun Wen, Gang Guo, MeiJuan Huang, Xia Zhao, ZhiYong Qian, YuQuan Wei.   

Abstract

Biodegradable cationic nanoparticles have promising application as a gene delivery system. In this article, heparin-polyethyleneimine (HPEI) nanogels were prepared, and these nanogels were developed as a nonviral gene vector. The transfection efficiency of HPEI nanogels was comparable with that of PEI25K, while the cytotoxicity was lower than that of PEI2K and much lower than that of PEI25K in vitro. These HPEI nanogels also had better blood compatibility than PEI25K. After intravenous administration, HPEI nanogels degraded, and the degradation products were excreted through urine. The plasmid expressing vesicular stomatitis virus matrix protein (pVSVMP) could be efficiently transfected into C-26 colon carcinoma cells by HPEI nanogels in vitro, inhibiting the cell proliferation through apoptosis induction. Intraperitoneal injection of pVSVMP/HPEI complexes efficiently inhibited the abdominal metastases of C-26 colon carcinoma through apoptosis induction (mean tumor weight in mice treated with pVSVMP/HPEI complex = 0.93 g and in control mice = 3.28 g, difference = 2.35 g, 95% confidence interval [CI] = 1.75-2.95 g, P < 0.001) and prolonged the survival of treated mice. Moreover, intravenous application of pVSVMP/HPEI complexes also inhibited the growth of pulmonary metastases of C-26 colon carcinoma through apoptosis induction. The HPEI nanogels delivering pVSVMP have promising application in treating colon carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20839784     DOI: 10.1021/nn1005599

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  23 in total

1.  Advances in the application of nanotechnology in the diagnosis and treatment of gastrointestinal tumors.

Authors:  B O Sun; Yantian Fang; Zhengyang Li; Zongyou Chen; Jianbin Xiang
Journal:  Mol Clin Oncol       Date:  2014-12-02

2.  Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma.

Authors:  Zhizhong Xu; Guobo Shen; Xiangying Xia; Xinyu Zhao; Peng Zhang; Huanhuan Wu; Qingfa Guo; Zhiyong Qian; Yuquan Wei; Shufang Liang
Journal:  J Transl Med       Date:  2011-04-23       Impact factor: 5.531

3.  Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.

Authors:  Ling Zhang; Xiang Gao; Ke Men; Bilan Wang; Shuang Zhang; Jinfeng Qiu; Meijuan Huang; Maling Gou; Ning Huang; Zhiyong Qian; Xia Zhao; Yuquan Wei
Journal:  Int J Nanomedicine       Date:  2011-10-19

4.  The study on the preparation and characterization of gene-loaded immunomagnetic albumin nanospheres and their anti-cell proliferative effect combined with magnetic fluid hyperthermia on GLC-82 cells.

Authors:  Hao Zhang; Xinxin Hou; Mei Lin; Ling Wang; Hongbo Li; Chenyan Yuan; Chen Liang; Jia Zhang; Dongsheng Zhang
Journal:  Drug Des Devel Ther       Date:  2015-12-15       Impact factor: 4.162

5.  Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.

Authors:  Yu Bai; Maling Gou; Tao Yi; Li Yang; Lili Liu; Xiaojuan Lin; Dan Su; Yuquan Wei; Xia Zhao
Journal:  Int J Med Sci       Date:  2015-05-08       Impact factor: 3.738

6.  Antitumor effect of D-erythrose in an abdominal metastatic model of colon carcinoma.

Authors:  Li-Li Liu; Tao Yi; Xia Zhao
Journal:  Oncol Lett       Date:  2014-12-03       Impact factor: 2.967

7.  Recent Progress of Polymeric Nanogels for Gene Delivery.

Authors:  Rima Kandil; Olivia M Merkel
Journal:  Curr Opin Colloid Interface Sci       Date:  2019-01-16       Impact factor: 6.448

8.  Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer.

Authors:  Xiang Gao; BiLan Wang; XiaWei Wei; Wang Rao; Fang Ai; Fen Zhao; Ke Men; Bowen Yang; Xingyu Liu; Meijuan Huang; Maling Gou; ZhiYong Qian; Ning Huang; Yuquan Wei
Journal:  Int J Nanomedicine       Date:  2013-03-08

9.  Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex.

Authors:  Zhi-Yao He; Feng Deng; Xia-Wei Wei; Cui-Cui Ma; Min Luo; Ping Zhang; Ya-Xiong Sang; Xiao Liang; Li Liu; Han-Xiao Qin; Ya-Li Shen; Ting Liu; Yan-Tong Liu; Wei Wang; Yan-Jun Wen; Xia Zhao; Xiao-Ning Zhang; Zhi-Yong Qian; Yu-Quan Wei
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

10.  Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.

Authors:  Jun Li; Jing Liu; Shengnan Li; Yanli Hao; Lei Chen; Xiaoning Zhang
Journal:  Oncotarget       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.